http://www.fpnotebook.com/

Recombinant Staphylokinase

See Also
1. Thrombolytic
Advantages
1. More fibrin specific then t-PA
2. Less likely to cause bleeding complications
  1. Hemorrhagic Cerebrovascular Accident
3. May yield better patency if given at twice dose
Disadvantages
1. Biological product generates immune response
  1. May only be able to give once
References
1. Vanderschueren (1995) Circulation 92:2044

Navigation Tree

Please see the Terms and Conditions. Please also see the privacy statement regarding advertising on this page. Although access to this page is not restricted, the information found here is intended for use by medical providers. Patients should address specific medical concerns with their physicians.

This page was written by Scott Moses, MD. This page was last revised before 5/10/08, prior to consistent tracking of revision date. This page was last published on 6/1/2008. Please send comments and questions to the editor. Contact information may be found on the page About the Family Practice Notebook. These pages are best viewed with Microsoft Internet Explorer 6.0.

Hematology and Oncology Book

Anemia

Blood Transfusion

Cancer

Coagulopathy

Hemoglobinopathies

Hemolytic Disorders

Lymphatic Disorders

Pathology and Laboratory Medicine

Platelet Disorders

Obstetrics Chapter related topics

http://www.fpnotebook.com/

Recombinant Staphylokinase

Navigation Tree